ArticleFrontiers in oncology2026

BRD4 PROTAC degrader enhances fulvestrant sensitivity in ER+ breast cancer via super-enhancer associated GREB1.

Xiulei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.